Switzerland
Noé Brasier
Noé Brasier (born 1983 in Bremerhaven, Germany) is a medical doctor by training with a specialization in internal medicine from the FMH Swiss Medical Association. His research focuses on the translation of wearable biofluid analysis into clinical application. Wearable biofluid analysis is a promising novel approach to revolutionize patient care by enabling continuous, mostly non-invasive, and lab-independent health and disease monitoring.
Noé graduated from MedSchool of the University of Basel, Switzerland, in 2015 and received his medical doctoral degree in 2018 from the University of Basel. After concluding his clinical training in internal medicine in 2021, he was awarded a MedLab Fellowship by the ETH Zurich, where he continued his research work at the Institute of Translational Medicine. Noé currently teaches translational medicine to students of ETH Zurich and also acts as a medical consultant for the BA in medicine at ETH Zurich.
The aim of this fellow project is to contribute to the fight against the silent pandemic of antimicrobials, as modern medicine finds itself at the edge of an abyss when it comes to the treatment of infectious diseases. For this, a cutting-edge concept of a wearable-based platform for therapeutic drug monitoring (TDM) of antimicrobials is designed within five interdisciplinary blocks (patient engagement, biomedical engineering, device cross-connectivity, clinics, and translational medicine). The different blocks are supported by distinguished, international experts of the respective fields. After the conclusion of the fellowship at the Collegium Helveticum, the final concept will be submitted for funding to develop a prototype for clinical testing.
pandemic of antimicrobials; modern medicine; therapeutic drug monitoring